Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Type II Diabetes

In brief

The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus

Key facts

Study ID

NCT05028140

Run by

EMS

People needed

480

Starts

2024-10-08

Expected to finish

2027-09-01

Last updated by the study team

2025-12-08

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the consent form;
• Diagnosis of type II diabetes mellitus, and who did not reach the therapeutic goal of HbA1c with previous dietary, physical exercise, and previous therapies at stable doses within 3 months.

You may not qualify if…

• Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of participants;
• History of alcohol abuse or illicit drug use;
• Participation in a clinical trial in the year prior to this study;
• Pregnancy or risk of pregnacy and lactating participants;
• Known hypersensitivity to any of the formula compounds;
• Type 1 diabetes.

Where it is running

• EMS — Hortolândia, São Paulo, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.